Clinical trial
OPTIMIZE Sirolimus-Eluting Coronary Stent Systems Pharmacokinetics (PK) Study
NCT03716102 is registered in ClinicalTrials.gov with Svelte Medical Systems, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- OPTIMIZE Sirolimus-Eluting Coronary Stent Systems Pharmacokinetics (PK) Study
- Lead sponsor
- Svelte Medical Systems, Inc.
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- November 21, 2018
- Completion date
- July 15, 2021
- Enrollment
- 12 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.